Chargement en cours...
Entecavir downregulates interleukin-37 in patients with chronic active hepatitis B infection
OBJECTIVES: Interleukin-37 (IL-37) has been identified as a potent inhibitor of the immune response. This study aimed to examine IL-37 expression in patients with chronic active hepatitis B (CAHB), and explore its possible regulatory role during inflammation. METHODS: Peripheral blood mononuclear ce...
Enregistré dans:
| Publié dans: | J Int Med Res |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7254606/ https://ncbi.nlm.nih.gov/pubmed/31939340 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060519884157 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|